quantisnow
FeedTopReportsPricing
⌘K
Live feed
19:32:43·45d
INSIDERFiling
Surgery Partners Inc. logo

COO & National Group President Oppenheimer Justin Robert was granted 42,523 shares, increasing direct ownership by 55% to 120,259 units (SEC Form 4)

SGRY· Surgery Partners Inc.
Health Care
Original source

Companies

  • SGRY
    Surgery Partners Inc.
    Health Care

Recent analyst ratings

  • Sep 18UpdateAnalyst$27.00
  • Jul 28UpdateBofA Securities$28.00
  • Dec 16UpdateBofA Securities$30.00
  • Oct 14UpdateUBS$38.00
  • Oct 11UpdateKeyBanc Capital Markets-
  • Jun 28UpdateMacquarie$31.00

Related

  • SEC8h
    SEC Form DEFA14A filed by Surgery Partners Inc.
  • SEC8h
    SEC Form DEF 14A filed by Surgery Partners Inc.
  • PR6d
    Surgery Partners, Inc. Announces First Quarter 2026 Earnings Release Date and Conference Call Details
  • SEC27d
    Amendment: SEC Form SCHEDULE 13G/A filed by Surgery Partners Inc.
  • INSIDER38d
    Chief Human Resources Officer Burkhalter Danielle sold $44,507 worth of shares (3,469 units at $12.83), decreasing direct ownership by 4% to 76,864 units (SEC Form 4)
  • INSIDER38d
    Chief Strategy Officer Brittenham Marissa sold $45,859 worth of shares (3,657 units at $12.54), decreasing direct ownership by 4% to 94,196 units (SEC Form 4)
  • INSIDER38d
    Chief Executive Officer Evans Jason Eric sold $254,388 worth of shares (20,400 units at $12.47), decreasing direct ownership by 2% to 920,386 units (SEC Form 4)
  • INSIDER38d
    Chief Financial Officer Doherty David T sold $110,838 worth of shares (8,867 units at $12.50), decreasing direct ownership by 4% to 221,679 units (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022